Literature DB >> 1767840

Islet cell responses to glucose in human transplanted pancreas.

D Elahi1, B A Clark, M McAloon-Dyke, G Wong, R Brown, M Shapiro, K L Minaker, T L Flanagan, T Pruett, R Gingerich.   

Abstract

Postsurgery, pancreas transplantation results in alterations of carbohydrate metabolism. Additionally, immunosuppressive therapy impacts on glucose regulation. We evaluated the hormonal and metabolic responses of pancreas allografts, utilizing the hyperglycemic clamp technique coupled with the tritiated glucose methodology, in 11 volunteers who had received simultaneous pancreas-kidney transplantation (P-K) with systemic drainage. Their responses were compared with seven volunteers who had received only a kidney (K) graft and with seven normal control (C) volunteers. Although basal glucose and hepatic glucose output were similar in all three groups, basal insulin, C-peptide, glucagon, and pancreatic polypeptide were highest in the P-K group and lowest in normal subjects. During hyperglycemia, all groups showed a similar characteristic, initial complete suppression of hepatic glucose production, with recovery followed by a later suppression. Peripheral glucose uptake was similar in P-K and C subjects but decreased in K patients. Systemic insulin levels were fourfold higher in the pancreas transplant patients than in healthy subjects. Thus, under basal and hyperglycemic stimulation, 1) hepatic glucose homeostasis is regulated normally, even with pancreatic drainage into the systemic circulation; 2) overall glucose disposal is normal in P-K patients because of marked hyperinsulinemia; and 3) there is loss of tonic inhibition of endocrine pancreatic function secondary to pancreatic denervation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1767840     DOI: 10.1152/ajpendo.1991.261.6.E800

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy.

Authors:  Atoosa Rabiee; Panagis Galiatsatos; Rocio Salas-Carrillo; Michael J Thompson; Dana K Andersen; Dariush Elahi
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

2.  The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs.

Authors:  J Radziuk; P Barron; H Najm; J Davies
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

3.  Hyperinsulinemia after pancreatic transplantation. Prediction by a novel computer model and in vivo verification.

Authors:  R C Earnhardt; D D Kindler; A M Weaver; G Cornett; D Elahi; J D Veldhuis; J B Hanks
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

4.  Diminished inhibitory effect of noradrenaline on insulin release from mouse islets transplanted to kidney.

Authors:  C L Shi; I B Täljedal
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

Review 5.  Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes.

Authors:  Michael R Rickels
Journal:  Ann N Y Acad Sci       Date:  2019-08-06       Impact factor: 5.691

6.  Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus.

Authors:  L Luzi; B J Hering; C Socci; G Raptis; A Battezzati; I Terruzzi; L Falqui; H Brandhorst; D Brandhorst; E Regalia; E Brambilla; A Secchi; G Perseghin; P Maffi; E Bianchi; V Mazzaferro; L Gennari; V Di Carlo; K Federlin; G Pozza; R G Bretzel
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.